Abstract
Correction: Risk for Recurrent Venous Thromboembolism and Bleeding With Apixaban Compared With Rivaroxaban <i>and</i> Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Valvular Atrial Fibrillation
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have